Canada Pharmaceuticals

Aequus Pharmaceuticals Inc (AQS)

Track

Ticker: AQS Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 25 Apr 2024
Value US$1,162,852.11 | Price 269.56 | Shares 20,584 (+7.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-21 2024-04-25 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
20,584 +7.9%
269.56
US$1,162,852 		20,584 +7.9% 269.56 US$1,162,852
2025-10-21 2024-03-04 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
55,194 -30.3%
411.65
US$1,305,036 		55,194 -30.3% 411.65 US$1,305,036
2025-10-21 2024-03-01 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
77,695 +47.0%
245.50
US$535,409 		77,695 +47.0% 245.50 US$535,409
2025-10-21 2024-02-29 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
108,000 +29.6%
0.02
US$1,620 		108,000 +29.6% 0.02 US$1,620
2025-10-21 2023-10-30 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
100,000 +37.7%
0.03
US$3,250 		100,000 +37.7% 0.03 US$3,250
2025-10-21 2022-12-16 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
265,000
0.03
US$6,625 		265,000 0.03 US$6,625
2022-11-30 2022-11-30 B Purchase
3.0
JANZEN, DOUG

Director of Issuer, Senior Officer of Issuer

Executive Director
285,000 +2.3%
0.04
CA$11,400 		285,000 +2.3% 0.04 CA$11,400
2025-10-21 2022-11-21 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
88,000 +1.3%
0.03
US$2,640 		88,000 +1.3% 0.03 US$2,640
2022-11-30 2022-11-20 B Purchase
3.0
JANZEN, DOUG

Director of Issuer, Senior Officer of Issuer

Executive Director
115,000
0.03
CA$3,450 		115,000 0.03 CA$3,450
2025-10-21 2022-11-18 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
12,000 +0.2%
0.03
US$360 		12,000 +0.2% 0.03 US$360
2022-09-07 2022-09-07 B Purchase
Fehr, Ann

Senior Officer of Issuer

Officer
47,000 +14.6%
0.07
CA$3,290 		47,000 +14.6% 0.07 CA$3,290
2022-09-07 2022-09-06 B Purchase
Fehr, Ann

Senior Officer of Issuer

Officer
10,000 +3.2%
0.06
CA$600 		10,000 +3.2% 0.06 CA$600
2022-08-26 2022-07-25 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
20,000
0.07
CA$1,300 		20,000 0.07 CA$1,300
2022-08-26 2022-07-25 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
16,000
0.06
CA$960 		16,000 0.06 CA$960
2022-08-26 2022-07-25 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
64,000
0.07
CA$4,480 		64,000 0.07 CA$4,480
2022-08-26 2022-07-22 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
26,000
0.07
CA$1,820 		26,000 0.07 CA$1,820
2022-08-26 2022-07-21 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
4,000
0.07
CA$280 		4,000 0.07 CA$280
2022-08-26 2022-07-20 B Purchase
2.8
Lustig, Marc

Director of Issuer

Non-Executive Director
120,000
0.07
CA$8,400 		120,000 0.07 CA$8,400
2022-07-20 2022-07-20 B Purchase
3.0
JANZEN, DOUG

Director of Issuer, Senior Officer of Issuer

Executive Director
100,000 +0.8%
0.08
CA$7,500 		100,000 +0.8% 0.08 CA$7,500
2022-07-19 2022-07-19 B Purchase
3.0
JANZEN, DOUG

Director of Issuer, Senior Officer of Issuer

Executive Director
1,000 +0.0%
0.08
CA$80 		1,000 +0.0% 0.08 CA$80
Explore more

More insider trading research around Aequus Pharmaceuticals Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America